Visit Here : http://bit.ly/2QBIUaO
Oral hypoglycemic agents (OHAs) are a group of drugs used to help reduce the amount of sugar present in the blood. They are not insulin, but they stimulate the pancreas to produce insulin.
At present, China is a country with the most populous victims of diabetes, SO, China will witness a huge potential in the OHAS market.
According to this study, over the next five years the Oral Hypoglyceimic Agents (OHAs) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Oral Hypoglyceimic Agents (OHAs) business, shared in Chapter 3.